These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 30068915)

  • 1. Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis.
    Li Z; Wu Z; Yan J; Liu H; Liu Q; Deng Y; Ou C; Chen M
    Lab Invest; 2019 Mar; 99(3):346-357. PubMed ID: 30068915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis.
    Yang W; Zhang S; Zhu J; Jiang H; Jia D; Ou T; Qi Z; Zou Y; Qian J; Sun A; Ge J
    J Mol Cell Cardiol; 2019 Sep; 134():119-130. PubMed ID: 31299216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure.
    Organ CL; Otsuka H; Bhushan S; Wang Z; Bradley J; Trivedi R; Polhemus DJ; Tang WH; Wu Y; Hazen SL; Lefer DJ
    Circ Heart Fail; 2016 Jan; 9(1):e002314. PubMed ID: 26699388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gut microbe-derived metabolite trimethylamine-N-oxide induces aortic valve fibrosis via PERK/ATF-4 and IRE-1α/XBP-1s signaling in vitro and in vivo.
    Xiong Z; Li J; Huang R; Zhou H; Xu X; Zhang S; Xie P; Li M; Guo Y; Liao X; Zhuang X
    Atherosclerosis; 2024 Apr; 391():117431. PubMed ID: 38408412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice.
    Zhang W; Miikeda A; Zuckerman J; Jia X; Charugundla S; Zhou Z; Kaczor-Urbanowicz KE; Magyar C; Guo F; Wang Z; Pellegrini M; Hazen SL; Nicholas SB; Lusis AJ; Shih DM
    Sci Rep; 2021 Jan; 11(1):518. PubMed ID: 33436815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlethal Inhibition of Gut Microbial Trimethylamine N-oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure.
    Organ CL; Li Z; Sharp TE; Polhemus DJ; Gupta N; Goodchild TT; Tang WHW; Hazen SL; Lefer DJ
    J Am Heart Assoc; 2020 May; 9(10):e016223. PubMed ID: 32390485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.
    Gupta N; Buffa JA; Roberts AB; Sangwan N; Skye SM; Li L; Ho KJ; Varga J; DiDonato JA; Tang WHW; Hazen SL
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1239-1255. PubMed ID: 32212854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
    Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
    Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
    Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
    J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbe-derived metabolite trimethylamine N-oxide activates the cardiac autonomic nervous system and facilitates ischemia-induced ventricular arrhythmia via two different pathways.
    Meng G; Zhou X; Wang M; Zhou L; Wang Z; Wang M; Deng J; Wang Y; Zhou Z; Zhang Y; Lai Y; Zhang Q; Yang X; Yu L; Jiang H
    EBioMedicine; 2019 Jun; 44():656-664. PubMed ID: 30954457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential relationship between gut microbes and atrial fibrillation: Trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation.
    Yu L; Meng G; Huang B; Zhou X; Stavrakis S; Wang M; Li X; Zhou L; Wang Y; Wang M; Wang Z; Deng J; Po SS; Jiang H
    Int J Cardiol; 2018 Mar; 255():92-98. PubMed ID: 29425570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,3-Dimethyl-1-butanol attenuates cardiac remodeling in pressure-overload-induced heart failure mice.
    Wang G; Kong B; Shuai W; Fu H; Jiang X; Huang H
    J Nutr Biochem; 2020 Apr; 78():108341. PubMed ID: 32004931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reductions in gut microbiota‑derived metabolite trimethylamine N‑oxide in the circulation may ameliorate myocardial infarction‑induced heart failure in rats, possibly by inhibiting interleukin‑8 secretion.
    Li X; Sun Y; Zhang X; Wang J
    Mol Med Rep; 2019 Jul; 20(1):779-786. PubMed ID: 31180562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity.
    Sun G; Yin Z; Liu N; Bian X; Yu R; Su X; Zhang B; Wang Y
    Biochem Biophys Res Commun; 2017 Nov; 493(2):964-970. PubMed ID: 28942145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 Signaling Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Hypertrophy and Fibrosis.
    Kumar S; Wang G; Zheng N; Cheng W; Ouyang K; Lin H; Liao Y; Liu J
    Hypertension; 2019 May; 73(5):1058-1070. PubMed ID: 30827145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
    Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of transforming growth factor-beta1 on rat cardiocyte hypertrophy].
    Huang J; Wei CY; Zheng ZQ; Wu YP; Deng YX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Aug; 22(3):283-7. PubMed ID: 21158069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
    Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
    Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice.
    Lee KN; Lu X; Nguyen C; Feng Q; Chidiac P
    J Mol Cell Cardiol; 2017 Jul; 108():194-202. PubMed ID: 28641980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.